Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash $ 8,690,784 $ 7,150,695
Prepaid expenses and other current assets 495,650 268,677
Australia research and development incentives receivable 53,608 144,680
Total current assets 9,240,042 7,564,052
Other assets 2,800 2,800
Total assets 9,242,842 7,566,852
Current liabilities:    
Accounts payable 1,152,055 1,638,546
Accrued expenses 2,456,844 3,298,607
Total current liabilities 3,608,899 4,937,153
Long term liabilities:    
Warrant liability 4,015,352 2,152,188
Total liabilities 7,624,251 7,089,341
Commitments and contingencies (Note 6)
Stockholders' equity    
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at September 30, 2024 and December 31, 2023, 0 shares issued and outstanding
Common stock, $0.0001 par value, 70,000,000 shares authorized at September 30, 2024 and December 31, 2023, 23,966,814 and 16,986,254 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 2,397 1,699
Additional paid-in capital 85,290,791 64,472,249
Accumulated deficit (83,662,895) (63,980,177)
Accumulated other comprehensive loss (11,702) (16,260)
Total stockholders' equity 1,618,591 477,511
Total liabilities and stockholders' equity $ 9,242,842 $ 7,566,852